Equus caballus (horse)

Summary
Taxonomy ID
9796
PubChem Taxonomy
9796
Displaying entries 426 - 450 of 1258 in total
Gene ID Gene Name ▲ Gene Symbol Disease Ontology
100052192 chondroitin sulfate N-acetylgalactosaminyltransferase 1
  • CSGALNACT1
100050200 chondroitin sulfate N-acetylgalactosaminyltransferase 2
  • CSGALNACT2
100061543 chondroitin sulfate proteoglycan 4
  • CSPG4
100064520 chondroitin sulfate proteoglycan 5
  • CSPG5
100057477 chondroitin sulfate synthase 1
  • CHSY1
100072984 chondroitin sulfate synthase 3
  • CHSY3
100053952 chondrolectin
  • CHODL
100033828 chromogranin A
  • CHGA
111770391 chromogranin A
  • CHGA
100146590 ciliary neurotrophic factor receptor
  • CNTFR
100052279 citrate synthase
  • CS
106781893 coiled-coil domain containing 115
  • CCDC115
100070236 collagen beta(1-O)galactosyltransferase 1
  • COLGALT1
100055683 collagen beta(1-O)galactosyltransferase 2
  • COLGALT2
100009713 collagen type IX alpha 2 chain
  • COL9A2
100065958 collectin subfamily member 10
  • COLEC10
100072828 collectin subfamily member 11
  • COLEC11
100060744 collectin subfamily member 12
  • COLEC12
100061294 component of oligomeric golgi complex 1
  • COG1
100065352 component of oligomeric golgi complex 2
  • COG2
100050896 component of oligomeric golgi complex 3
  • COG3
100054801 component of oligomeric golgi complex 4
  • COG4
100060129 component of oligomeric golgi complex 5
  • COG5
100050872 component of oligomeric golgi complex 6
  • COG6
100068356 component of oligomeric golgi complex 7
  • COG7

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024